Literature DB >> 34292998

Ward-level factors associated with methicillin-resistant Staphylococcus aureus acquisition-an electronic medical records study in Singapore.

Zaw Myo Tun1, Dale A Fisher2,3, Sharon Salmon4, Clarence C Tam1,5.   

Abstract

BACKGROUND: Methicillin-Resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide. Intrahospital transfers may impact MRSA acquisition risk experienced by patients. In this study, we investigated ward characteristics and connectivity that are associated with MRSA acquisition.
METHODS: We analysed electronic medical records on patient transfers and MRSA screening of in-patients at an acute-care tertiary hospital in Singapore to investigate whether ward characteristics and connectivity within a network of in-patient wards were associated with MRSA acquisition rates over a period of four years.
RESULTS: Most patient transfers concentrated in a stable core network of wards. Factors associated with increased rate of MRSA acquisition were MRSA prevalence among patients transferred from other wards (rate ratio (RR): 7.74 [95% confidence interval (CI): 3.88, 15.44], additional 5 percentage point), critical care ward (RR: 1.72 [95% CI: 1.09, 2.70]) and presence of MRSA cohorting beds (RR: 1.39 [95% CI: 1.03, 1.90]. Oncology ward (RR: 0.66 [95% CI: 0.46, 0.94]) (compared to medical ward), and median length of stay (RR: 0.70 [95% CI: 0.55, 0.90], additional 1.5 days) were associated with lower acquisition rates. In addition, we found evidence of interaction between MRSA prevalence among patients transferred from other wards and weighted in-degree although the latter was not associated with MRSA acquisition after controlling for confounders.
CONCLUSION: Wards with higher MRSA prevalence among patients transferred from other wards were more likely to have higher MRSA acquisition rate. Its effect further increased in wards receiving greater number of patients. In addition, critical care ward, presence of MRSA cohorting beds, ward specialty, and median length of stay were associated with MRSA acquisition.

Entities:  

Year:  2021        PMID: 34292998     DOI: 10.1371/journal.pone.0254852

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  35 in total

1.  Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study.

Authors:  G Dziekan; A Hahn; K Thüne; G Schwarzer; K Schäfer; F D Daschner; H Grundmann
Journal:  J Hosp Infect       Date:  2000-12       Impact factor: 3.926

2.  Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital.

Authors:  Jo-anne M Salangsang; Lee H Harrison; Maria M Brooks; Kathleen A Shutt; Melissa I Saul; Carlene A Muto
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  MRSA colonization and acquisition in the burn unit: A systematic review and meta-analysis.

Authors:  Markos Kalligeros; Fadi Shehadeh; Spyridon A Karageorgos; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Burns       Date:  2019-06-13       Impact factor: 2.744

4.  Hospital Staffing and Health Care-Associated Infections: A Systematic Review of the Literature.

Authors:  Brett G Mitchell; Anne Gardner; Patricia W Stone; Lisa Hall; Monika Pogorzelska-Maziarz
Journal:  Jt Comm J Qual Patient Saf       Date:  2018-06-13

5.  Risk Factors for Nosocomial Methicillin Resistant Staphylococcus aureus (MRSA) Colonization in a Neonatal Intensive Care Unit: A Case-Control Study.

Authors:  Archana Balamohan; Joanna Beachy; Nina Kohn; Lorry G Rubin
Journal:  Am J Infect Control       Date:  2021-04-30       Impact factor: 2.918

6.  Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing.

Authors:  James R Price; Kevin Cole; Andrew Bexley; Vasiliki Kostiou; David W Eyre; Tanya Golubchik; Daniel J Wilson; Derrick W Crook; A Sarah Walker; Timothy E A Peto; Martin J Llewelyn; John Paul
Journal:  Lancet Infect Dis       Date:  2016-11-16       Impact factor: 25.071

7.  Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Authors:  Athena P Kourtis; Kelly Hatfield; James Baggs; Yi Mu; Isaac See; Erin Epson; Joelle Nadle; Marion A Kainer; Ghinwa Dumyati; Susan Petit; Susan M Ray; David Ham; Catherine Capers; Heather Ewing; Nicole Coffin; L Clifford McDonald; John Jernigan; Denise Cardo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-08       Impact factor: 17.586

8.  Sustained meticillin-resistant Staphylococcus aureus control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore.

Authors:  D Fisher; P A Tambyah; R T P Lin; R Jureen; A R Cook; A Lim; B Ong; M Balm; T M Ng; L Y Hsu
Journal:  J Hosp Infect       Date:  2013-09-05       Impact factor: 3.926

9.  Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore.

Authors:  Mar-Kyaw Win; Tarek Abdellatif Aly Soliman; Linda Kay Lee; Chia Siong Wong; Angela Chow; Brenda Ang; Carrasco L Roman; Yee-Sin Leo
Journal:  BMC Infect Dis       Date:  2015-09-29       Impact factor: 3.090

10.  Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit.

Authors:  Mirian Freitas DalBen; Mariusa Basso; Cilmara Polido Garcia; Silvia Figueiredo Costa; Cristiana Maria Toscano; William Robert Jarvis; Renata Desordi Lobo; Maura Salaroli Oliveira; Anna Sara Levin
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more
  1 in total

1.  Cost effectiveness of temporary isolation rooms in acute care settings in Singapore.

Authors:  Nicholas Graves; Yiying Cai; Brett Mitchell; Dale Fisher; Martin Kiernan
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.